All Atrial fibrillation articles
-
NewsRenal decline slower with rivaroxaban than warfarin in patients with atrial fibrillation
Patients with atrial fibrillation report fewer adverse renal outcomes and a slower decline in renal function on rivaroxaban compared with warfarin
-
Upcoming Live Webinars
The impact of DOACs on stroke in patients with NVAF: practical considerations for those with comorbidities
This promotional webinar has been funded by Bristol Myers Squibb on behalf of the BMS – Pfizer Alliance and organised in partnership with Guidelines.
ELIQUIS (apixaban) prescribing and adverse event reporting information.
432-GB-2100774 | August 2021 -
NICE guideline
NICE atrial fibrillation guideline
A clear summary of NICE’s guideline on atrial fibrillation management
-
Hosted content
Calculating renal function in patients with atrial fibrillation
This animation has been developed and funded by the Bristol Myers Squibb/Pfizer Alliance and is intended for UK healthcare professionals.
432-GB-2100230 June 2021 -
News
NICE publishes new atrial fibrillation guideline
NICE’s new guideline Atrial fibrillation: diagnosis and management updates and replaces NICE guideline CG180, and includes recommendations for providing the best care and treatment for adults with atrial fibrillation
-
Video
The holistic management of patients requiring anticoagulation
This video has been commissioned and funded by Bayer plc and developed in partnership with Guidelines.
View Xarelto▼(rivaroxaban) prescribing information and adverse event reporting
PP-XAR-GB-1924 January 2021 -
Independent professional body guideline
AWMSG advice on oral anticoagulation for non-valvular atrial fibrillation
Recommendations for primary care on the role of oral anticoagulant treatment in people with non-valvular atrial fibrillation.
-
Working party guideline/algorithm
Consensus guideline on the holistic management of patients requiring anticoagulation
This guideline was developed by a multidisciplinary expert panel: Fay M et al with the support of an educational grant from Bayer plc.
-
SIGN guideline
SIGN cardiac arrhythmias guideline
Read the latest recommendations on the management of atrial fibrillation and ventricular arrhythmias in acute coronary syndrome, coronary heart disease, and left-ventricular dysfunction as well as arrhythmias associated with cardiac arrest and coronary artery bypass graft.
-
News
Quality standard on AF updated by NICE
NICE has updated Quality Standard 93 on Atrial fibrillation.
